SECURITIES AND EXCHANGE COMMISSION
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
July 7, 2003
Date of Report (Date of Earliest Event Reported)
Schering-Plough Corporation
New Jersey | 1-6571 | 22-1918501 | ||
(State or other jurisdiction of incorporation) |
(Commission File Number) | (IRS Employer Identification Number) |
2000 Galloping Hill Road
Kenilworth, NJ 07033
(Address of principal executive offices, including Zip Code)
(908) 298-4000
(Registrants telephone number, including area code)
Item 5. Other Events and Regulation FD Disclosure | ||||||||
Item 7. Financial Statements and Exhibits | ||||||||
SIGNATURES | ||||||||
Exhibit Index | ||||||||
PRESS RELEASE | ||||||||
PRESS RELEASE | ||||||||
PRESS RELEASE |
Item 5. Other Events and Regulation FD Disclosure
Schering-Plough Corporation on July 7, 2003 issued press releases titled Schering-Plough Comments on Earnings Outlook, Fred Hassan, Schering-Plough Chairman and CEO, Highlights Several New Action Steps in Turnaround Program, and Schering-Plough Announces New Organizational Structure For Global Pharmaceutical Business. The press releases are attached to this 8-K as Exhibits 99.1, 99.2 and 99.3, respectively.
Item 7. Financial Statements and Exhibits
(c) Exhibits. The following exhibits are filed with this 8-K:
99.1 Press Release Dated July 7, 2003, Titled Schering-Plough Comments on Earnings Outlook
99.2 Press Release Dated July 7, 2003, Titled Fred Hassan, Schering-Plough Chairman and CEO, Highlights Several New Action Steps in Turnaround Program
99.3 Press Release Dated July 7, 2003, Titled Schering-Plough Announces New Organizational Structure For Global Pharmaceutical Business
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Schering-Plough Corporation
By: /s/Thomas H. Kelly
Thomas H. Kelly
Vice President and Controller
Date: July 7, 2003
Exhibit Index
The following exhibits are filed with this 8-K:
99.1 Press Release Dated July 7, 2003, Titled Schering-Plough Comments on Earnings Outlook
99.2 Press Release Dated July 7, 2003, Titled Fred Hassan, Schering-Plough Chairman and CEO, Highlights Several New Action Steps in Turnaround Program
99.3 Press Release Dated July 7, 2003, Titled Schering-Plough Announces New Organizational Structure For Global Pharmaceutical Business